1. Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma
   Meghan M. Bell et al, 2020, Molecules CrossRef
2. Critical Investigation of the Usability of Hepatoma Cell Lines HepG2 and Huh7 as Models for the Metabolic Representation of Resectable Hepatocellular Carcinoma
   Gerda Schicht et al, 2022, Cancers CrossRef
3. Association between air pollution and primary liver cancer in European and east Asian populations: a Mendelian randomization study
   Mengting Sun et al, 2023, Frontiers in Public Health CrossRef
4. Elucidation of the Usefulness of Glypican-3, a Hepatocellular Carcinoma Biomarker, with the Fully Automated LUMIPULSE^® System
   Hisashi Nojima et al, 2023, BPB Reports CrossRef
5. Targeted and Multifunctional Technology for Identification between Hepatocellular Carcinoma and Liver Cirrhosis
   Han Deng et al, 2019, ACS Applied Materials & Interfaces CrossRef
6. Multi-Modal Imaging Probe for Glypican-3 Overexpressed in Orthotopic Hepatocellular Carcinoma
   Shuo Feng et al, 2021, Journal of Medicinal Chemistry CrossRef
7. Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment
   Mengtao Xing et al, 2021, International Journal of Molecular Sciences CrossRef
8. Identification of a Glypican‐3‐Binding Peptide for In Vivo Non‐Invasive Human Hepatocellular Carcinoma Detection
   Zainen Qin et al, 2017, Macromolecular Bioscience CrossRef
9. The Expression of Glypican-3 in Colorectal Cancer
   Sonia Azizpour et al, 2019, Cytology and Genetics CrossRef